Investors
Press Releases
Events & Presentations
Corporate Governance
Financial Information
Stock Information
Investor FAQs
Contact Us
Investors  >  Press Releases

Press Releases

All Releases
View Summary Enzymotec Ltd. Reports Second Quarter 2017 Unaudited Financial Results
Aug 16, 2017
PDF 58.5 KB Add to Briefcase
View Summary Enzymotec Ltd. Announces Appointment of Dror Israel as Chief Financial Officer
Jul 28, 2017
PDF 14.0 KB Add to Briefcase
View Summary Enzymotec to Report Second Quarter 2017 Financial Results
Jul 26, 2017
PDF 9.5 KB Add to Briefcase
View Summary Enzymotec Chief Financial Officer to Step Down
Jun 28, 2017
PDF 13.6 KB Add to Briefcase
View Summary Enzymotec Launches Next Generation Krill Oil Product - K•REAL® Gold
Jun 6, 2017
PDF 11.7 KB Add to Briefcase
View Summary Enzymotec Ltd. to Present at the Jefferies 2017 Global Healthcare Conference
May 25, 2017
PDF 8.3 KB Add to Briefcase
View Summary Enzymotec Ltd. Reports First Quarter 2017 Unaudited Financial Results
May 17, 2017
PDF 47.6 KB Add to Briefcase
View Summary Enzymotec to Report First Quarter 2017 Financial Results
May 3, 2017
PDF 9.8 KB Add to Briefcase
View Summary Neptune and Enzymotec Reach Patent Agreement Ending All Litigation
Apr 3, 2017
PDF 14.7 KB Add to Briefcase
View Summary Enzymotec Files Annual Report on Form 20-F for the Year Ended December 31, 2016
Mar 16, 2017
PDF 10.0 KB Add to Briefcase
View Summary Enzymotec Ltd. Calls an Extraordinary General Meeting of Shareholders
Mar 10, 2017
PDF 14.7 KB Add to Briefcase
View Summary Enzymotec Ltd. Announces the Appointment of Erez Israeli as President and CEO
Mar 9, 2017
PDF 13.7 KB Add to Briefcase
View Summary Enzymotec Ltd. Reports Fourth Quarter and Full Year 2016 Unaudited Financial Results
Feb 22, 2017
PDF 63.3 KB Add to Briefcase
View Summary Enzymotec Ltd. Announces Preliminary Fourth Quarter and Full Year 2016 Financial Results
Feb 6, 2017
PDF 17.0 KB Add to Briefcase
View Summary Enzymotec Ltd. Reports Third Quarter 2016 Unaudited Financial Results
Nov 16, 2016
PDF 61.1 KB Add to Briefcase
View Summary Enzymotec Ltd. Announces Departure of its CEO
Nov 16, 2016
PDF 13.5 KB Add to Briefcase
View Summary Enzymotec to Report Third Quarter 2016 Financial Results
Nov 2, 2016
PDF 9.8 KB Add to Briefcase
View Summary Enzymotec Ltd. Granted New Patents for INFAT® in the U.S., Vayacog® in Japan and Phospholipid-Based Products in Canada and Korea
Sep 27, 2016
PDF 15.1 KB Add to Briefcase
View Summary Enzymotec Ltd. Reports Second Quarter 2016 Unaudited Financial Results
Aug 9, 2016
PDF 60.0 KB Add to Briefcase
View Summary Enzymotec Ltd. To Present at Two Upcoming Investor Conferences
Aug 2, 2016
PDF 8.9 KB Add to Briefcase
Showing 1-20 of 103 Page: 1 2 3 4 5 6  Next 20
Add to Briefcase = add release to Briefcase
  Home Page | Site Map | Contact Us  
Signed by CDTech - Web Development and Design  
Disclaimer: These statements have not been evaluated by the Food and Drug Administration.
These products are not intended to diagnose, treat , cure or prevent disease.
Copyright (©) 2013 Enzymotec Ltd. All rights reserved.